PODCAST · health
From Clues to Care: Improving Recognition and Treatment of Alpha-Mannosidosis
by Annenberg Center for Health Sciences
Alpha mannosidosis (AM) is a rare, progressive lysosomal disorder with a broad and heterogeneous clinical phenotype that can evolve across the lifespan. Drawing on the 2024 Global Delphi Consensus Recommendations and other recent evidence, this activity focuses on practical, clinician oriented strategies for baseline and longitudinal assessment, use of enzyme replacement therapy and hematopoietic stem cell transplantation, monitoring treatment response and disease progression, and the coordination of interprofessional, multidisciplinary care essential for patient management.
-
4
Patient-Centered Holistic Care
Integrated Care CoordinationConsensus Recommendations for Routine Follow-UpCare in AM Detailed Assessment Recommendations by BodySystem
-
3
Standard of Care Treatment and Monitoring for AM
Enzyme Replacement Therapy (Velmanase Alfa)Pivotal Trials of Velmanase Alfa in AMHematopoietic Stem Cell TransplantConsensus Recommendations for Monitoring Treatment
-
2
Identification and Diagnosis of AM
Phenotypic Subtypes of AMGuidelines for Genetic TestingDiagnostic Algorithms for AMConsensus Recommendations for Testing andBaseline Assessment
-
1
Introduction to Alpha-Mannosidosis (AM)
DescriptionEpidemiologyCase Vignette
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Alpha mannosidosis (AM) is a rare, progressive lysosomal disorder with a broad and heterogeneous clinical phenotype that can evolve across the lifespan. Drawing on the 2024 Global Delphi Consensus Recommendations and other recent evidence, this activity focuses on practical, clinician oriented strategies for baseline and longitudinal assessment, use of enzyme replacement therapy and hematopoietic stem cell transplantation, monitoring treatment response and disease progression, and the coordination of interprofessional, multidisciplinary care essential for patient management.
HOSTED BY
Annenberg Center for Health Sciences
Loading similar podcasts...
Frequently Asked Questions
How many episodes does From Clues to Care: Improving Recognition and Treatment of Alpha-Mannosidosis have?
From Clues to Care: Improving Recognition and Treatment of Alpha-Mannosidosis currently has 4 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is From Clues to Care: Improving Recognition and Treatment of Alpha-Mannosidosis about?
Alpha mannosidosis (AM) is a rare, progressive lysosomal disorder with a broad and heterogeneous clinical phenotype that can evolve across the lifespan. Drawing on the 2024 Global Delphi Consensus Recommendations and other recent evidence, this activity focuses on practical, clinician oriented...
How often does From Clues to Care: Improving Recognition and Treatment of Alpha-Mannosidosis release new episodes?
From Clues to Care: Improving Recognition and Treatment of Alpha-Mannosidosis has 4 episodes. Check the episode list to see recent publication dates and frequency.
Where can I listen to From Clues to Care: Improving Recognition and Treatment of Alpha-Mannosidosis?
You can listen to From Clues to Care: Improving Recognition and Treatment of Alpha-Mannosidosis on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts From Clues to Care: Improving Recognition and Treatment of Alpha-Mannosidosis?
From Clues to Care: Improving Recognition and Treatment of Alpha-Mannosidosis is created and hosted by Annenberg Center for Health Sciences.
URL copied to clipboard!